US Stock MarketDetailed Quotes

CUE Cue Biopharma

Watchlist
  • 1.840
  • -0.030-1.60%
Trading Nov 12 14:58 ET
110.78MMarket Cap-1896P/E (TTM)

Cue Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cue Biopharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 5.226M--
--2024/Q3-- / 1.520M--
--2024/Q22.658M / 1.289M--
--2024/Q11.717M / 1.213M--
--2023/Q41.821M / 1.567M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 5.226M--
--2024/Q3-- / 1.520M--
--2024/Q22.658M / 1.289M--
--2024/Q11.717M / 1.213M--
--2023/Q41.821M / 1.567M--

Unlock Free Earnings Estimates

Cue Biopharma Earnings Reports

  • Cue Biopharma | 10-Q: Q2 2024 Earnings Report

    Aug 14 16:07 ET

  • Cue Biopharma | 10-Q: Q1 2024 Earnings Report

    May 9 16:05 ET

  • Cue Biopharma | 10-K: FY2023 Annual Report

    Mar 28 22:41 ET

  • Cue Biopharma | 10-Q: Q3 2023 Earnings Report

    Nov 3, 2023 16:15 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 31, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data